Australia's Creso Pharma up on FY revenue rise

Melodiol Global Health

31/01/2023 02:52

** Shares of Creso Pharma Ltd  CPH.AX  rise as much as 2.4%
to A$0.022, on track for best day since Jan. 24
    ** Cannabis company posts total FY22 unaudited revenue of
A$9 mln ($6.35 mln), up 44% 
    ** Says there was 32% reduction in cash burn from operations
from FY21 to FY22
    ** More than 4.5 mln shares change hands, vs 30-day average
volume of 3.6 mln shares
    ** Stock up 5% this year, as of last close
($1 = 1.4182 Australian dollars)
 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))